Skip to main content

Table 1 Baseline characteristics of study

From: Efficacy of azithromycin in sepsis-associated acute respiratory distress syndrome: a retrospective study and propensity score analysis

Factor Group Overall
   N = 125
Age,y   75 [66, 82]
Sex M/F 85(68.0)/40 (32.0)
Cirrhosis No/Yes 112 (89.6)/13(10.4)
Sepsis Pulmonary 78 (62.4)
  Nonpulmonary 47 (37.6)
APACHE.II   23 [18, 27]
McCabe 1/2/3 114 (91.2)/5(4.0)/6(4.8)
ARDS severity Mild 10 (8.0)
  Moderate 58 (46.4)
  Severe 57 (45.6)
SOFA   7 [5, 11]
PaO2/FiO2, mmHg   106.80 [75.1, 139.7]
CT.score   213.3 [184.8, 268.5]
Albumin, g/dL   2.8 [2.40, 3.20]
WBC   9600 [4200, 14,400]
C-reactive protein, mg/dL   15.94 [9.01, 25.70]
Lactate dehydrogenase, IU/L   308 [246, 434]
DIC score   3 [2, 4]
FDP, mg/L   11.10 [1.50, 170.70]
Antithrombin III  %   66.00 [52.00, 80.00]
Platelet, X104   17.90 [10.10, 26.40]
D.dimer.μg/ml.   5.60 [2.70, 11.00]
AZM use (%)   29(23.2)
Death (%)   58 (46.4)
  1. n (%), median [IQR]
  2. APACHE acute physiology and chronic health evaluation, ARDS acute respiratory distress syndrome, AZM azithromycin, DIC disseminated intravascular coagulation, FDP fibrin/fibrinogen degradation products, SOFA Sequential Organ Failure Assessment score, WBC white blood cell count